Estrogen and raloxifene, a selective estrogen receptor modulator, ameliorate renal damage in db/db mice.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  American Journal of Pathology

• Publication date

  2005-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0002-9440(10)62473-XPMID 15920148PMCID PMC1602422
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Autoimmune glomerulonephritis with spontaneous formation of splenic germinal centers in mice lacking the estrogen receptor alpha gene.

  2004cited by this paper
• Peroxisome proliferator-activated receptor-gamma ligands inhibit TGF-beta 1-induced fibronectin expression in glomerular mesangial cells.

  2004cited by this paper
• Transforming growth factor β1-induced glomerulopathy is prevented by 17β-estradiol supplementation

  2004cited by this paper
• Peroxisome proliferator-activated receptor-γ ligands inhibit TGF-β1-induced fibronectin expression in glomerular mesangial cells

  2004cited by this paper
• Beneficial Effects of Estrogens on Indices of Renal Damage in Uninephrectomized SHRsp Rats.

  2004cited by this paper
• Glomerulosclerosis and tubulointerstitial fibrosis are attenuated with 17beta-estradiol in the aging Dahl salt sensitive rat.

  2004cited by this paper
• The impact of gender on progression of renal disease: potential role of estrogen-mediated vascular endothelial growth factor regulation and vascular protection.

  2004cited by this paper
• Transforming growth factor beta1-induced glomerulopathy is prevented by 17beta-estradiol supplementation.

  2004cited by this paper
• Estrogen deficiency accelerates progression of glomerulosclerosis in susceptible mice.

  2003cited by this paper
• Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial.

  2003cited by this paper
• Different Effects of Castration and Estrogen Administration on Glomerular Injury in Spontaneously Hyperglycemic Otsuka Long-Evans Tokushima Fatty (OLETF) Rats

  2002cited by this paper
• Raloxifene and cardiovascular events in osteoporotic postmenopausal women: four-year results from the MORE (Multiple Outcomes of Raloxifene Evaluation) randomized trial.

  2002cited by this paper
• Raloxifene does not affect insulin sensitivity or glycemic control in postmenopausal women with type 2 diabetes mellitus: a randomized clinical trial.

  2002cited by this paper
• Estradiol upregulates mesangial cell MMP-2 activity via the transcription factor AP-2.

  2002cited by this paper
• Estrogen-related abnormalities in glomerulosclerosis-prone mice: reduced mesangial cell estrogen receptor expression and prosclerotic response to estrogens.

  2002cited by this paper
• Role of 17β-estradiol administration on insulin sensitivity in the rat: implications for the insulin receptor

  2002cited by this paper
• Smad pathway is activated in the diabetic mouse kidney and Smad3 mediates TGF-beta-induced fibronectin in mesangial cells.

  2002cited by this paper
• Raloxifene and Cardiovascular Events in Osteoporotic Postmenopausal Women: Four-Year Results From the MORE (Multiple Outcomes of Raloxifene Evaluation) Randomized Trial

  2002cited by this paper
• Protein kinase CK2 mediates TGF-beta1-stimulated type IV collagen gene transcription and its reversal by estradiol.

  2001cited by this paper
• Expression and regulation of estrogen receptors in mesangial cells: influence on matrix metalloproteinase-9.

  2001cited by this paper
• Protein kinase CK2 mediates TGF-β;1-stimulated type IV collagen gene transcription and its reversal by estradiol1

  2001cited by this paper
• Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice.

  2000cited by this paper
• Selective estrogen receptor modulators suppress mesangial cell collagen synthesis.

  2000cited by this paper
• The effects of hormone replacement therapy and raloxifene on C-reactive protein and homocysteine in healthy postmenopausal women: a randomized, controlled trial.

  2000cited by this paper
• Reduction of Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis Treated With Raloxifene: Results From a 3-year Randomized Clinical Trial

  2000cited by this paper
• Effect of gender on the progression of nondiabetic renal disease: a meta-analysis.

  2000cited by this paper
• Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC β inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes

  2000cited by this paper
• Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators.

  1999cited by this paper
• Estradiol suppresses mesangial cell type I collagen synthesis via activation of the MAP kinase cascade.

  1999cited by this paper
• Estradiol suppresses mesangial cell type I collagen synthesis via activation of the MAP kinase cascade.

  1999cited by this paper
• Raloxifene, a New Selective Estrogen Receptor Modulator

  1999cited by this paper
• Estradiol reverses TGF-β1-stimulated type IV collagen gene transcription in murine mesangial cells.

  1998cited by this paper
• Estrogen accelerates the development of renal disease in female obese Zucker rats.

  1998cited by this paper
• Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites.

  1997cited by this paper
• The cytoskeletal linking proteins, moesin and radixin, are upregulated by platelet-derived growth factor, but not basic fibroblast growth factor in experimental mesangial proliferative glomerulonephritis.

  1996cited by this paper
• Effects of sex hormones on mesangial cell proliferation and collagen synthesis.

  1996cited by this paper
• Transforming growth factor beta in tissue fibrosis.

  1994cited by this paper
• Transforming Growth Factor β in Tissue Fibrosis

  1994cited by this paper
• Prevalence of Complications in IDDM by Sex and Duration: Pittsburgh Epidemiology of Diabetes Complications Study II

  1990cited by this paper
• Epidemiology of Persistent Proteinuria in Type II Diabetes Mellitus: Population-Based Study in Rochester, Minnesota

  1988cited by this paper
• Female Sex Hormone and Nephropathy in Cohen Diabetic Rat (Genetically Selected Sucrose-Fed)

  1984cited by this paper
• The effects of steroids on the incidence of diabetes in rats after subtotal pancreatectomy.

  1950cited by this paper

• Steroid hormones and nephrolithiasis: regulation of urine components metabolism and inflammation

  2026cites this paper
• Ovarian Aging: Mechanisms, Age‐Related Disorders, and Therapeutic Interventions

  2025cites this paper
• Kidney Health and Gender-Affirming Hormone Therapy for Transgender and Gender Diverse Individuals.

  2025cites this paper
• Dietary Quercetin Intake Is Associated With a Lower Risk of Diabetic Nephropathy in US Adults: Data From NHANES 2007–2008, 2009–2010, and 2017–2018

  2025cites this paper
• Ovarian Aging: The Silent Catalyst of Age-Related Disorders in Female Body

  2025cites this paper
• Chronic kidney disease and menopausal health: An EMAS clinical guide.

  2024cites this paper
• Sex-Related Aspects in Diabetic Kidney Disease—An Update

  2023cites this paper
• The potential renoprotective effect of Raloxifene in renal ischemia-reperfusion injury in a male rat model

  2023cites this paper
• Role of Sex Hormones in Prevalent Kidney Diseases

  2023cites this paper
• Role of sex hormones in diabetic nephropathy

  2023cites this paper
• Mechanism of Cornus Officinalis in Treating Diabetic Kidney Disease Based on Network Pharmacology

  2022cites this paper
• Correlation Between Cardiometabolic Index and Microalbuminuria in Type 2 Diabetic Patients

  2021cites this paper
• Gender Differences in Diabetic Kidney Disease: Focus on Hormonal, Genetic and Clinical Factors

  2021cites this paper
• Estrogen and estrogen receptors in kidney diseases

  2021cites this paper
• Sex differences in renal mitochondrial function: a hormone-gous opportunity for research.

  2020cites this paper
• Sex Differences in Diabetes- and TGF-β1-Induced Renal Damage

  2020cites this paper
• Estrogen regulates aquaporin-2 expression in the kidney.

  2020cites this paper
• Preventive effect of exercise training on diabetic kidney disease in ovariectomized rats with type 1 diabetes

  2019cites this paper
• Protein O-GlcNAcylation Is Essential for the Maintenance of Renal Energy Homeostasis and Function via Lipolysis during Fasting and Diabetes.

  2019cites this paper
• Effect of moderate exercise on renal changes and oxidative stress in ovariectomized rats with type 1 diabetes mellitus

  2019cites this paper
• Influence of Sex on the Progression of Chronic Kidney Disease.

  2019cites this paper
• Tamoxifen ameliorates obstructive nephropathy through Src and the PI3K/Akt/mTOR pathway

  2018cites this paper
• Transcriptional Profile of Kidney from Type 2 Diabetic db/db Mice

  2017cites this paper
• Parp1 protects against Aag-dependent alkylation-induced nephrotoxicity in a sex-dependent manner

  2016cites this paper
• ISN Forefronts Symposium 2015: Nuclear Receptors and Diabetic Nephropathy

  2016cites this paper
• RAS and sex differences in diabetic nephropathy.

  2016cites this paper
• Sex Differences and Renal Protection: Keeping in Touch with Your Feminine Side.

  2016cites this paper
• The protective role of G protein-coupled estrogen receptor 1 (GPER-1) on methotrexate-induced nephrotoxicity in human renal epithelium cells

  2016cites this paper
• Effect of Raloxifen on Renal Function in Post-Menopausal Women with Diabetic Nephropathy: a Double Blind Clinical Trial

  2013cites this paper
• The benefits of estrogen or selective estrogen receptor modulator on kidney and its related disease—chronic kidney disease—mineral and bone disorder: Osteoporosis

  2013cites this paper
• Renal anemia: from incurable to curable.

  2013cites this paper
• Selective estrogen receptor modulation attenuates proteinuria-induced renal tubular damage by modulating mitochondrial oxidative status.

  2013cites this paper
• Raloxifene Upregulated Mesangial Cell MMP-2 Activity via ER-β Through Transcriptional Regulation

  2013cites this paper
• Effects of Pharmaceutical Mestranol on Estrogen Receptor β mRNA Expression Levels and Morphometry in the Anal Fins of Adult Thai Ricefi sh (Oryzias minutillus)

  2012cites this paper
• Combined inhibition of aromatase activity and dihydrotestosterone supplementation attenuates renal injury in male streptozotocin (STZ)-induced diabetic rats.

  2012cites this paper
• in male streptozotocin ( STZ )-induced diabetic rats dihydrotestosterone supplementation attenuates renal Combined inhibition of aromatase activity and

  2012cites this paper
• An investigation on body weights, blood glucose levels and pituitary-gonadal axis hormones in diabetic and metformin-treated diabetic female rats

  2012cites this paper
• Antifibrotic effect of tamoxifen in a model of progressive renal disease.

  2012cites this paper
• Renal and glycemic effects of high-dose chromium picolinate in db/db mice: assessment of DNA damage.

  2012cites this paper
• Estrogen receptor-alpha mediates Toll-like receptor-2 agonist-induced monocyte chemoattractant protein-1 production in mesangial cells.

  2012cites this paper
• ULTRASTRUCTURAL STUDY OF GRANULOSA CELLS IN OVARIAN FOLLICLES OF DIABETIC AND METFORMIN-TREATED DIABETIC RATS SUBSEQUENT TO INDUCTION OF EXPRIMENTAL DIABETES

  2012cites this paper
• Phosphatidylinositol 3-Kinase/Akt Signaling Pathway Activates the WNK-OSR1/SPAK-NCC Phosphorylation Cascade in Hyperinsulinemic db/db Mice

  2012cites this paper
• Fluorofenidone Attenuates Diabetic Nephropathy and Kidney Fibrosis in db/db Mice

  2011cites this paper
• Estrogens and progression of diabetic kidney damage.

  2011cites this paper
• Raloxifene reduces blood pressure in hypertensive animals after ovarian hormone deprivation.

  2011cites this paper
• Midkine, a heparin-binding protein, is increased in the diabetic mouse kidney postmenopause.

  2011cites this paper
• Raloxifene, a selective estrogen receptor modulator, is renoprotective: a post-hoc analysis.

  2011cites this paper
• Effect of 17-Β Estradiol Supplementation on Reversion of Diabetic Renal Fibrosis

  2011cites this paper
• Testosterone and 17β-estradiol have opposite effects on podocyte apoptosis that precedes glomerulosclerosis in female estrogen receptor knockout mice.

  2011cites this paper
• Expression of aromatase, androgen and estrogen receptors in peripheral target tissues in diabetes.

  2010cites this paper
• Dose-dependent effects of dihydrotestosterone in the streptozotocin-induced diabetic rat kidney.

  2009cites this paper
• Estradiol restores diabetes-induced reductions in sex steroid receptor expression and distribution in the vagina of db/db mouse model.

  2009cites this paper
• Exendin-4 has an anti-hypertensive effect in salt-sensitive mice model.

  2009cites this paper
• Estradiol ameliorates diabetes-induced changes in vaginal structure of db/db mouse model.

  2009cites this paper
• Sex, diabetes and the kidney.

  2009cites this paper
• Association of urinary albumin excretion with insulin resistance in Japanese subjects: impact of gender difference on insulin resistance.

  2009cites this paper
• Diabetes Attenuates Female Genital Sexual Arousal Response via Disruption of Estrogen Action

  2009cites this paper
• Animal models of diabetes mellitus: relevance to vascular complications.

  2008cites this paper
• Estrogens and the diabetic kidney.

  2008cites this paper
• Diabetic kidney disease in the VCD model of menopause

  2008cites this paper
• Rein et diabète

  2008cites this paper
• Estrogens and progesterone as neuroprotectants: what animal models teach us.

  2008cites this paper
• Comparative effects of estradiol, methyl-piperidino-pyrazole, raloxifene, and ICI 182 780 on gene expression in the murine uterus.

  2008cites this paper
• Gender and human chronic renal disease.

  2008cites this paper
• The effects of the selective estrogen receptor modulators MPP and raloxifene in normal and cancerous human and murine uterine tissue

  2007cites this paper
• CALL FOR PAPERS Sex Differences in Renal and Cardiovascular Function: Physiology and Pathophysiology 17-Estradiol supplementation reduces tubulointerstitial fibrosis by increasing MMP activity in the diabetic kidney

  2007cites this paper
• Effect of raloxifene—a selective oestrogen receptor modulator—on kidney function in post‐menopausal women with Type 2 diabetes: results from a randomized, placebo‐controlled pilot trial

  2007cites this paper
• The Effect of Alendronate, Risedronate, and Raloxifene on Renal Functions, Based on the Cockcroft and Gault Method, in Postmenopausal Women

  2007cites this paper
• 17beta-Estradiol attenuates diabetic kidney disease by regulating extracellular matrix and transforming growth factor-beta protein expression and signaling.

  2007cites this paper
• Role of altered renal lipid metabolism in the development of renal injury induced by a high-fat diet.

  2007cites this paper
• 17beta-Estradiol supplementation reduces tubulointerstitial fibrosis by increasing MMP activity in the diabetic kidney.

  2007cites this paper
• Gender Differences in the Renin-Angiotensin and Nitric Oxide Systems: Relevance in the Normal and Diseased Kidney

  2007cites this paper
• Renoprotective Effects of a Selective Estrogen Receptor Modulator, Raloxifene, in an Animal Model of Diabetic Nephropathy

  2007cites this paper
• ANGIOTENSIN-CONVERTING ENZYME INHIBITOR CAPTOPRIL PREVENTS OLEIC ACID-INDUCED SEVERE ACUTE LUNG INJURY IN RATS

  2007cites this paper
• Gender-specific effects of endogenous testosterone: female alpha-estrogen receptor-deficient C57Bl/6J mice develop glomerulosclerosis.

  2007cites this paper
• MMP activity in the diabetic kidney

  2006cites this paper
• Growth factor midkine is involved in the pathogenesis of diabetic nephropathy.

  2006cites this paper
• The Effect of Flutamide on Systemic and Renal Hemodynamics in Zucker Diabetic Rats: Paradoxic Renal Vasodilator Response to Endothelin-1 and TXA2 Receptor Activation in Female Sex

  2006cites this paper
• Differential effects of continuous and intermittent 17beta-estradiol replacement and tamoxifen therapy on the prevention of glomerulosclerosis: modulation of the mesangial cell phenotype in vivo.

  2006cites this paper
• Small animal models of cardiovascular disease: tools for the study of the roles of metabolic syndrome, dyslipidemia, and atherosclerosis.

  2006cites this paper
• MIT Open

  year unknowncites this paper